Maternal use of nicotine products and breastfeeding 3 months postpartum.


Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
12 2020
Historique:
received: 12 09 2019
revised: 27 03 2020
accepted: 01 04 2020
pubmed: 11 4 2020
medline: 15 5 2021
entrez: 11 4 2020
Statut: ppublish

Résumé

We aimed to determine the prevalence of and factors associated with maternal use of nicotine products in relation to breastfeeding. Nicotine use 3 months postpartum was determined in the Scandinavian PreventADALL mother-child birth cohort study recruiting 1837 women from 2014 to 2016. Electronic questionnaires at 18 weeks pregnancy and 3 months postpartum provided information on snus use, smoking or other nicotine use, infant feeding and socio-economic factors. The risk of nicotine use in relation to breastfeeding was analysed with logistic regression. Overall, 5.6% of women used snus (2.9%), smoked (2.7%) or both (n = 2) 3 months postpartum, while one used other nicotine products. Among the 1717 breastfeeding women, 95.1% reported no nicotine use, while 2.4% used snus, 2.5% smoked and one dual user. Compared to 3.7% nicotine use in exclusively breastfeeding women (n = 1242), the risk of nicotine use increased by partly (OR 2.26, 95% CI 1.45-3.52) and no breastfeeding (OR 4.58, 95% CI 2.57-8.21). Nicotine use before (14.5% snus, 16.4% smoking) or in pregnancy (0.2% snus, 0.4% smoking) significantly increased the risk of using nicotine during breastfeeding. Few breastfeeding women used snus or smoked 3 months postpartum, with increased risk by nicotine use before or during pregnancy.

Identifiants

pubmed: 32274823
doi: 10.1111/apa.15299
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2594-2603

Investigateurs

Anna Asarnoj (A)
Oda C Lødrup Carlsen (OC)
Åshild Wik Despriée (Å)
Vibeke Dyrseth (V)
Kim A Endre (KA)
Peder A Granlund (PA)
Henrik Holmstrøm (H)
Geir Håland (G)
Caroline-Aleksi O Mägi (CO)
Unni C Nygaard (UC)
Knut Rudi (K)
Carina M Saunders (CM)
Kathrine D Sjøborg (KD)
Ingebjørg Skrindo (I)
Sandra G Tedner (SG)
Magdalena R Vaernesbranden (MR)
Johanna Wiik (J)

Informations de copyright

© 2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.

Références

The Global Burden of Diseases I, and Risk Factors Study (GBD). Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885-1906.
Kreyberg I, Nordhagen LS, Bains KES, et al. An update on prevalence and risk of snus and nicotine replacement therapy during pregnancy and breastfeeding. Acta Paediatr. 2019;108:1215-1221.
Inamdar AS, Croucher RE, Chokhandre MK, Mashyakhy MH, Marinho VC. Maternal smokeless tobacco use in pregnancy and adverse health outcomes in newborns: a systematic review. Nicotine Tob Res. 2015;17(9):1058-1066.
Dahlstrom A, Ebersjo C, Lundell B. Nicotine exposure in breastfed infants. Acta Paediatr. 2004;93(6):810-816.
Nordenstam F, Lundell B, Edstedt Bonamy AK, Raaschou P, Wickström R. Snus users had high levels of nicotine, cotinine and 3-hydroxycotinine in their breastmilk, and the clearance was slower than in smoking mothers. Acta Paediatr. 2019;108:1250-1255.
Napierala M, Mazela J, Merritt TA, Florek E. Tobacco smoking and breastfeeding: effect on the lactation process, breast milk composition and infant development. A critical review. Environ Res. 2016;151:321-338.
Banderali G, Martelli A, Landi M, et al. Short and long term health effects of parental tobacco smoking during pregnancy and lactation: a descriptive review. J Transl Med. 2015;13:327.
Nafstad P, Jaakkola JJ, Hagen JA, Botten G, Kongerud J. Breastfeeding, maternal smoking and lower respiratory tract infections. Eur Respir J. 1996;9(12):2623-2629.
Dahlstrom A, Ebersjo C, Lundell B. Nicotine in breast milk influences heart rate variability in the infant. Acta Paediatr. 2008;97(8):1075-1079.
Lauria L, Lamberti A, Grandolfo M. Smoking behaviour before, during, and after pregnancy: the effect of breastfeeding. Sci World J. 2012;2012:1-9.
The National Board of Health and Welfare. The National Board of Health and Welfare Stockholm 2019 [cited 17.desember 2019]. https://www.socialstyrelsen.se/statistik-och-data/statistik/
Orton S, Coleman T, Coleman-Haynes T, Ussher M. Predictors of postpartum return to smoking: a systematic review. Nicotine Tob Res. 2018;20(6):665-673.
Rockhill KM, Tong VT, Farr SL, Robbins CL, D'Angelo DV, England LJ. Postpartum smoking relapse after quitting during pregnancy: pregnancy risk assessment monitoring system, 2000-2011. J Women's Health. 2016;25(5):480-488.
Dahlin S, Gunnerbeck A, Wikstrom AK, Cnattingius S. Edstedt Bonamy AK. Maternal tobacco use and extremely premature birth - a population-based cohort study. BJOG. 2016;14:14.
Kreyberg I, Bains KES, Carlsen KH, et al. Stopping when knowing: use of snus and nicotine during pregnancy in Scandinavia. ERJ Open Res. 2019;5:2.
The Norwegian Directorate of Health. Amming og spedbarns kosthold Oslo: the Norwegian directorate of health; 2014 [cited 18. desember 2019]. https://www.helsedirektoratet.no/search?searchquery=amming
Barrington-Trimis JL, Leventhal AM. Adolescents' use of "Pod Mod" E-Cigarettes - urgent concerns. N Engl J Med. 2018;379(12):1099-1102.
Lodrup Carlsen KC, Rehbinder EM, Skjerven HO, et al. Preventing atopic dermatitis and ALLergies in Children-the PreventADALL study. Allergy. 2018;73:2063-2097.
Liu J, Rosenberg KD, Sandoval AP. Breastfeeding duration and perinatal cigarette smoking in a population-based cohort. Am J Public Health. 2006;96(2):309-314.
Statistics Norway. Statistics Norway Oslo: Statistics Norway; 2019 [cited 18. December 2019]. https://www.ssb.no/
Statistics Sweden. Statistic Sweden Stockholm: Statistic Sweden; 2019 [cited 18. December 2019]. https://www.scb.se/en/
Logan CA, Rothenbacher D, Genuneit J. Postpartum smoking relapse and breast feeding: defining the window of opportunity for intervention. Nicotine Tob Res. 2016;19:367-372.
Horta BL, Kramer MS, Platt RW. Maternal smoking and the risk of early weaning: a meta-analysis. Am J Public Health. 2001;91(2):304.
Harmer C, Memon A. Factors associated with smoking relapse in the postpartum period: an analysis of the child health surveillance system data in southeast England. Nicotine Tob Res. 2013;15(5):904-909.
Norwegian Institute of Public Health. Røyking og snusbruk i Noreg Oslo: Norwegian Institute of Public Health; 2018 [cited 18. desember 2019]. https://www.fhi.no/nettpub/hin/levevaner/royking-og-snusbruk-i-noreg/
Tong VT, Jones JR, Dietz PM, D’Angelo D, Bombard JM. Trends in smoking before, during, and after pregnancy-Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005. MMWR Morb Mortal Wkly Rep. 2009;58(4):1-31.
Cooper S, Orton S, Leonardi-Bee J, et al. Smoking and quit attempts during pregnancy and postpartum: a longitudinal UK cohort. BMJ Open. 2017;7(11):e018746.
Mattsson K, Kallen K, Rignell-Hydbom A, et al. Cotinine validation of self-reported smoking during pregnancy in the Swedish medical birth register. Nicotine Tob Res. 2016;18(1):79-83.
Kvalvik LG, Nilsen RM, Skjaerven R, et al. Self-reported smoking status and plasma cotinine concentrations among pregnant women in the Norwegian Mother and Child Cohort Study. Pediatr Res. 2012;72(1):101-107.

Auteurs

Live S Nordhagen (LS)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
VID Specialized University, Oslo, Norway.

Ina Kreyberg (I)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Karen Eline S Bains (KES)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Kai-Håkon Carlsen (KH)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Kari Glavin (K)

VID Specialized University, Oslo, Norway.

Håvard O Skjerven (HO)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Milada C Småstuen (MC)

VID Specialized University, Oslo, Norway.

Katarina Hilde (K)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.

Björn Nordlund (B)

Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Riyas Vettukattil (R)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Gunilla Hedlin (G)

Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Berit Granum (B)

Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.

Christine M Jonassen (CM)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway.
Genetic Unit, Centre for Laboratory Medicine, Østfold Hospital Trust, Kalnes, Norway.

Hrefna K Gudmundsdóttir (HK)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Guttorm Haugen (G)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.

Eva Maria Rehbinder (EM)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Department of Dermatology, Oslo University Hospital, Oslo, Norway.

Cilla Söderhäll (C)

Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Anne Cathrine Staff (AC)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.

Karin C Lødrup Carlsen (KC)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH